ERBB2 and breast carcinoma: Previously, it was shown that the paired box 2 gene product (PAX2), a transcription factor that physically associates with an ER binding site [75] within the intron of the ERBB2 gene and inhibits the transcription of ERBB2, enhanced the sensitivity of breast cancer cells to tamoxifen treatment [18].